NASDAQ:NURO
NeuroMetrix Stock News
$4.30
-0.170 (-3.80%)
At Close: May 03, 2024
NeuroMetrix Announces Issuance of New U.S. Patent for Quell® Wearable Technology
05:00pm, Monday, 21'st Sep 2020
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office will issue on September 22, 2020 U.S. Patent No. 10,780,269 titled
Quell® Fills Unmet Need for Chronic Knee Pain Relief that is Drug-Free
02:00pm, Monday, 10'th Aug 2020
WOBURN, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) published an infographic on chronic knee pain (available here) and provided an update on how Quell technology address
NeuroMetrix Reports Q2 2020 Financial Results
11:00am, Thursday, 23'rd Jul 2020
WOBURN, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2020. The Company is a leading develop
NeuroMetrix's (NURO) CEO Shai Gozani on Q2 2020 Results - Earnings Call Transcript
09:00am, Thursday, 23'rd Jul 2020
NeuroMetrix, Inc. (NASDAQ:NURO) Q2 2020 Earnings Conference Call July 23, 2020, 8:00 am ET Company Participants Thomas Higgins - SVP & CFO Shai Gozani - President & CEO Conference Call Partici
The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results
12:00am, Thursday, 23'rd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
ABIOMED, Inc. (NASDAQ: ABMD)
Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO)
Bio-Rad Laboratories,...
Joseph McCormick, takes over Vanguard Capital Equities as the new Executive Vice President & Chief Operating Officer
11:11pm, Tuesday, 21'st Jul 2020
McCormick is taking on the Vanguard. Experience infusions to build on the Quantum Leap philosophy. Full power blast foreword.
Global Beta-Glucan Ingredient Market Study 2020 - ResearchAndMarkets.com
12:00am, Friday, 17'th Jul 2020
The
NeuroMetrix, Inc. Announces Date for Second Quarter 2020 Financial Results Conference Call
07:14pm, Thursday, 16'th Jul 2020
WOBURN, Mass., July 16, 2020 -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2020 second quarter financial results before the opening of the.
Sensus Healthcare to Present at COVID-19 Webinar Hosted by Maxim Group on July 16th | MarketScreener
08:03pm, Monday, 13'th Jul 2020Neurometrix (NASDAQ:NURO) Stock Price Down 7.1%
03:36am, Sunday, 12'th Jul 2020
Shares of Neurometrix Inc (NASDAQ:NURO) fell 7.1% during trading on Friday . The stock traded as low as $2.06 and last traded at $2.09, 829,259 shares changed hands during trading. An increase of 0% f
NeuroMetrix Reports DPNCheck® Expansion in China
05:00pm, Thursday, 09'th Jul 2020
WOBURN, Mass., July 09, 2020 -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction.
Central Hudson Expands Distributed Energy Resource Capabilities with Sensus
12:00am, Tuesday, 07'th Jul 2020
Central Hudson Gas & Electric Corporation partners with Sensus to adapt their existing infrastructure into a sustainable, clean energy solution.
Suiker Unie macht unter dem Namen Cosun Beet Company weiter
02:01pm, Thursday, 02'nd Jul 2020
Fokus auf Kreislaufwirtschaft mit Zuckerrüben im Mittelpunkt
NeuroMetrix Signs DPNCheck® Collaboration Agreement with Biomedix
05:00pm, Thursday, 25'th Jun 2020
WOBURN, Mass., June 25, 2020 -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has signed a collaboration agreement with Biomedix to comarket DPNCheck for peripheral.
